McLenachan S - Search Results

1

Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line.

Zhang X, Zhang D, Chen SC, Lamey T, Thompson JA, McLaren T, De Roach JN, Chen FK, McLenachan S. Zhang X, et al. Among authors: mclenachan s. Stem Cell Res. 2018 May;29:245-249. doi: 10.1016/j.scr.2018.04.014. Epub 2018 May 1. Stem Cell Res. 2018. PMID: 29753273 Free article.

2

Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells.

McLenachan S, Menchón C, Raya A, Consiglio A, Edel MJ. McLenachan S, et al. Stem Cells Dev. 2012 Oct 10;21(15):2891-9. doi: 10.1089/scd.2012.0190. Epub 2012 Jun 25. Stem Cells Dev. 2012. PMID: 22500553 Free PMC article.

3

Plant hormones increase efficiency of reprogramming mouse somatic cells to induced pluripotent stem cells and reduce tumorigenicity.

Alvarez Palomo AB, McLenachan S, Requena Osete J, Menchón C, Barrot C, Chen F, Munné-Bosch S, Edel MJ. Alvarez Palomo AB, et al. Among authors: mclenachan s. Stem Cells Dev. 2014 Mar 15;23(6):586-93. doi: 10.1089/scd.2013.0292. Epub 2014 Jan 7. Stem Cells Dev. 2014. PMID: 24251409 Free PMC article.

4

mRNA transfection of mouse and human neural stem cell cultures.

McLenachan S, Zhang D, Palomo AB, Edel MJ, Chen FK. McLenachan S, et al. PLoS One. 2013 Dec 26;8(12):e83596. doi: 10.1371/journal.pone.0083596. eCollection 2013. PLoS One. 2013. PMID: 24386231 Free PMC article.

5

Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration.

Alvarez Palomo AB, McLenachan S, Chen FK, Da Cruz L, Dilley RJ, Requena J, Lucas M, Lucas A, Drukker M, Edel MJ. Alvarez Palomo AB, et al. Among authors: mclenachan s. Fibrogenesis Tissue Repair. 2015 May 15;8:9. doi: 10.1186/s13069-015-0026-9. eCollection 2015. Fibrogenesis Tissue Repair. 2015. PMID: 25984235 Free PMC article.

6

Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.

McLenachan S, Magno AL, Ramos D, Catita J, McMenamin PG, Chen FK, Rakoczy EP, Ruberte J. McLenachan S, et al. Exp Eye Res. 2015 Sep;138:6-21. doi: 10.1016/j.exer.2015.06.023. Epub 2015 Jun 26. Exp Eye Res. 2015. PMID: 26122048

7

The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.

Palomo AB, Lucas M, Dilley RJ, McLenachan S, Chen FK, Requena J, Sal MF, Lucas A, Alvarez I, Jaraquemada D, Edel MJ. Palomo AB, et al. Among authors: mclenachan s. J Clin Med. 2014 Apr 4;3(2):373-87. doi: 10.3390/jcm3020373. J Clin Med. 2014. PMID: 26237380 Free PMC article. Review.

8

iPS Cells for Modelling and Treatment of Retinal Diseases.

Chen FK, McLenachan S, Edel M, Da Cruz L, Coffey PJ, Mackey DA. Chen FK, et al. Among authors: mclenachan s. J Clin Med. 2014 Dec 19;3(4):1511-41. doi: 10.3390/jcm3041511. J Clin Med. 2014. PMID: 26237613 Free PMC article. Review.

9

Past, Present, and Future Concepts of the Choroidal Scleral Interface Morphology on Optical Coherence Tomography.

Huynh E, Chandrasekera E, Bukowska D, McLenachan S, Mackey DA, Chen FK. Huynh E, et al. Among authors: mclenachan s. Asia Pac J Ophthalmol (Phila). 2017 Jan-Feb;6(1):94-103. doi: 10.22608/APO.201698. Asia Pac J Ophthalmol (Phila). 2017. PMID: 28161920 Free article. Review.

10

Human limbal neurospheres prevent photoreceptor cell death in a rat model of retinal degeneration.

McLenachan S, Zhang D, Hao E, Zhang L, Chen SC, Chen FK. McLenachan S, et al. Clin Exp Ophthalmol. 2017 Aug;45(6):613-624. doi: 10.1111/ceo.12940. Epub 2017 Apr 19. Clin Exp Ophthalmol. 2017. PMID: 28256796 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters